Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain control methods for surgical management of incomplete miscarriage at Princess Marina Hospital
PACTR202502619751607Phase 0Not yet recruiting
- Sponsor
- Catherine Raletsatsi
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of lidocaine in incomplete spontaneous abortion (3 arms), sponsored by Catherine Raletsatsi. Primary endpoints: Pain control across the 3 methods of analgesia being studied and Complications of the 3 methods of analgesia being studied. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
incomplete spontaneous abortion
Beyond the preview
Go deeper on PACTR202502619751607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502619751607.